Furthermore, a significant (p < 0.05) positive correlation between ESR1 and S100A8 and S100A9 gene expression levels was observed in basal breast cancer patients; whereas such a correlation was significantly (p < 0.05) negative in the Her2, Luminal A, and Luminal B types of breast cancer patients. This evidence concerns the gene S100A9 and breast cancer.